<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02641613</url>
  </required_header>
  <id_info>
    <org_study_id>CCVEM 038/15</org_study_id>
    <nct_id>NCT02641613</nct_id>
  </id_info>
  <brief_title>Retroclavicular Versus Supraclavicular Brachial Plexus Block for Hand and Forearm Surgery</brief_title>
  <official_title>The Efficacy of Retroclavicular Versus Supraclavicular Brachial Plexus Block in Patients Undergoing Forearm and Hand Surgery: a Randomized Controlled Double-blinded Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hôpital du Valais</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hôpital du Valais</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients will be randomized to one of two groups:

        1. Supraclavicular group: supraclavicular brachial plexus block performed with the aid of
           ultrasound;

        2. Retroclavicular group: retroclavicular brachial plexus block performed with the aid of
           ultrasound.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be proposed to all patients undergoing formarm or hand surgery under brachial
      plexus block. Patients will be randomized to one of two groups The first group -
      supraclavicular group - will receive an ultrasound-guided brachial plexus block via the
      supraclavicular approach, by injection of 30 ml of a mixture of ropivacaine 0.5 % +
      mepivacaine 1 %. The second group - retroclavicular group - will receive an ultrasound-guided
      brachial plexus block via the retroclavicular approach, by injection of 30 ml of a mixture of
      ropivacaine 0.5 % + mepivacaine 1 %. Primary outcome is success rate at 30 minutes after the
      injection defined as loss of sensation to pinprick in the forearm and hand. Secondary
      outcomes are: needling time, time to first analgesic request, postoperative opioid
      consumption, pain scores at 12 and 24 hours postoperatively, block-related complications, and
      patient satisfaction.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2016</start_date>
  <completion_date type="Actual">May 2018</completion_date>
  <primary_completion_date type="Actual">May 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success rate (loss of sensation to pinprick in the forearm and hand)</measure>
    <time_frame>30 minutes after the injection</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Needling time in seconds</measure>
    <time_frame>15 min</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time to first analgesic request</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Block-related complications</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Postoperative opioid consumption on postoperative day 1</measure>
    <time_frame>24 hours</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scores at 12 hours postoperatively</measure>
    <time_frame>12 hours</time_frame>
    <description>measured on a visual analogue scale between 0 and 100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain scores on postoperative day 1</measure>
    <time_frame>24 hours</time_frame>
    <description>measured on a visual analogue scale between 0 and 100</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction as assessed by numerical rating scale</measure>
    <time_frame>24 hours</time_frame>
    <description>Patient satisfaction on a scale between 0 (= completely dissatisfied) and 10 (= completely satisfied)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Hand Injury</condition>
  <arm_group>
    <arm_group_label>supraclavicular</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>patients receive a supraclavicular block for forearm or hand surgery with 30 ml of a mixture of ropivacaine 0.5 % and mepivacaine 1 %</description>
  </arm_group>
  <arm_group>
    <arm_group_label>retroclavicular block</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>patients receive a retroclavicular block for forearm or hand surgery with 30 ml of a mixture of ropivacaine 0.5 % and mepivacaine 1 %</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>retroclavicular block</intervention_name>
    <description>retroclavicular block for forearm or hand surgery</description>
    <arm_group_label>retroclavicular block</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>supraclavicular block</intervention_name>
    <description>supraclavicular block for forearm or hand surgery</description>
    <arm_group_label>supraclavicular</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients who undergo forearm or hand surgery under brachial plexus block.

        Exclusion Criteria:

          -  History of allergic reaction to local anaesthetics

               -  Peripheral neuropathy

               -  Renal or hepatic insufficiency

               -  Coagulation disorders
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sina Grape, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hopital du Valais</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Eric Albrecht, MD</last_name>
    <role>Study Director</role>
    <affiliation>CHUV</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hopital du Valais</name>
      <address>
        <city>Sion</city>
        <zip>1950</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>May 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 1, 2015</study_first_submitted>
  <study_first_submitted_qc>December 23, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 29, 2015</study_first_posted>
  <last_update_submitted>May 8, 2018</last_update_submitted>
  <last_update_submitted_qc>May 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 9, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hôpital du Valais</investigator_affiliation>
    <investigator_full_name>Sina Grape</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hand Injuries</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

